Fruquintinib (Elunate)
Revision as of 14:59, 8 July 2018 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== VEGFR inhibitor ==Preliminary data== ===Colon cancer=== *'''FRESCO:''' Li J, Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H,...")
Mechanism of action
VEGFR inhibitor
Preliminary data
Colon cancer
- FRESCO: Li J, Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Fan S, Hua Y, Su W. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial. JAMA. 2018 Jun 26;319(24):2486-2496. link to original article PubMed
Also known as
- Code name: HMPL-013